#IDIBELLfellows: Lorenzo Torreni / Elisabet Munté
Gut microbiota in X-ALD patients: an overlooked player on the field? Lorenzo Torreni – Neurometabolic diseases Group…
Gut microbiota in X-ALD patients: an overlooked player on the field? Lorenzo Torreni – Neurometabolic diseases Group…
Tumours undergo constant Darwinian evolution and clonal diversification, the net result of which tends to be increased…
Envejecemos a partir de los 40-50 años (algunos incluso antes). Cuando nos miramos en el espejo percibimos…
From Senescence to cell death: exploring novel therapeutic approaches in Malignant Pleural Mesothelioma (MPM) Iswarya Sreeram –…
Research misconduct is an understudied topic. Behind the classic publish or perish axiom, there are multiple and…
New frontiers in cancer therapies and personalized medicine Barcelona, October 3rd – 4th, 2024 Venue: Auditorium HUB…
13 de maig a les 15.30 h | Sala d’Actes de l’Hospital Universitari de Bellvitge Jornada acreditada…
Us presentem el programa de l’edició EMDebate d’enguany. Hem convidat a alguns dels principals especialistes en esclerosi…
Des de la Unitat d’Esclerosi Múltiple EMxarxa us presentem el programa de sessions “Actualización en Esclerosis Múltiple”,…
Drug resistance in cancer is often linked to changes in tumor cell state or lineage, but the…